We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Supplementing the Diet with Broccoli Sprouts May Reduce Risk of Stomach Cancer

By LabMedica International staff writers
Posted on 21 Apr 2009
A team of American and Japanese pharmacologists has found that supplementing the diet with fresh broccoli sprouts inhibits the growth of Helicobacter pylori, bacteria that cause gastric ulcers and have been implicated as a major cause of stomach cancer.

Broccoli sprouts are a rich source of isothiocyanate sulforaphane (SF), which is known for its anticancer properties. More...
In the current study, which was published in the April 1, 2009, issue of the journal Cancer Prevention Research, investigators have shown that SF is powerfully bactericidal against H. pylori infections.

Oral treatment with SF-rich broccoli sprouts of C57BL/6 female mice infected with H. pylori and maintained on a high-salt (7.5% NaCl) diet reduced gastric bacterial colonization and lowered all measurable immunological and biochemical markers of H. pylori infection.

In another study 48 H. pylori-infected Japanese men and women were randomly assigned to eat 70 grams of fresh broccoli sprouts daily for eight weeks or an equivalent amount of alfalfa sprouts (lacking SF). The investigators determined the initial severity of H. pylori infection and again at four and eight weeks using standard breath, serum, and stool tests. Results showed that H. pylori levels were significantly lower at eight weeks on all three measures among those patients who had eaten broccoli sprouts, while they remained the same for patients who had eaten alfalfa sprouts.

"Broccoli has recently entered the public awareness as a preventive dietary agent. This study supports the emerging evidence that broccoli sprouts may be able to prevent cancer in humans, not just in lab animals," said contributing author Dr. Jed Fahey, research associate in pharmacology at Johns Hopkins University (Baltimore, MD, USA).

Related Links:
Johns Hopkins University



New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Urine Chemistry Control
Dropper Urine Chemistry Control
New
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: Prof. Nicholas Schwab has found a biomarker that can predict treatment outcome of glatirameracetate in MS patients (Photo courtesy of Uni MS - M. Ibrahim)

Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients

Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.